Skip to main content

BIO-TECHNE Corp diluted shares

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

BIO-TECHNE Corp's diluted shares was 157M shares for fiscal year 2026 (the twelve months to 30 Jun 2026), down 1.7% from fiscal 2025.

In the first quarter of fiscal 2027 (the three months to 30 Sep 2026) it was 158M shares, up 1.0% from a year earlier.

From BIO-TECHNE Corp's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 6 Nov 2026.

Fiscal 2026
157M
−1.7%
Q1 FY2027
158M
+1.0% on a year
Growth over 9 years
+0.5%
a year, FY 2017–FY 2026

Diluted shares by fiscal year

150MFY 2017152MFY 2018+1.5%156MFY 2019+2.2%158MFY 2020+1.3%162MFY 2021+2.7%164MFY 2022+1.3%162MFY 2023−1.4%161MFY 2024−0.7%160MFY 2025−0.7%157MFY 2026−1.7%

Change on the year before, under each year. From FY 2017 to FY 2026, BIO-TECHNE Corp's diluted shares went from 150M shares to 157M shares, a compound annual change of +0.5%; the highest was 164M shares in FY 2022.

BIO-TECHNE Corp diluted shares, fiscal years
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Diluted shares150M152M156M158M162M164M162M161M160M157M
Period end30 Jun 201730 Jun 201830 Jun 201930 Jun 202030 Jun 202130 Jun 202230 Jun 202330 Jun 202430 Jun 202530 Jun 2026

Diluted shares by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

BIO-TECHNE Corp diluted shares, fiscal quarters
PeriodQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Diluted shares161M159M157M156M157M157M157M158M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How diluted shares is measured

Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

BIO-TECHNE Corp's other figures

Diluted shares of comparable companies

Everything on TECH, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.